RESPIRE-EXCEL Respiratory Precision Medicine PhD Training Network- Excellence through Systems Biology, Spatial and Single-cell Transcriptomics
- Coordinator
- Academisch Ziekenhuis Groningen, Netherlands
- Runs
- 1 March 2025 to 28 February 2029
- Status
- Running
- EU funding
- €3.3m
- Total cost
- —
- Partners
- 27 organisations in 11 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101169403
What the project is doing
In the project's own words, from its summary on CORDIS.
Asthma and COPD are prevalent, chronic respiratory diseases, with high incidence and societal costs. Current treatment is based on a ‘one-size-fits-all’ approach, that suppresses symptoms, but fails to achieve stable remission of disease. There is an urgent need to replace these generic treatments with precision medicine for asthma and COPD. This transition is hampered by the complexity of asthma and COPD on the one hand, and by the lack of an integrated, multidisciplinary approach to achieve progress towards precision medicine for these chronic respiratory disorders on the other hand.
The complexity of asthma and COPD is caused by multiple molecular mechanisms that independently contribute to the pathogenesis of disease. Their activity varies over time, and between patients, leading to substantial heterogeneity of asthma and COPD: identical clinical phenotypes can be caused by dissimilar molecular and cellular mechanisms, and requiring different treatments. The vision of RESPIRE-EXCEL is to achieve the transition to precision medicine in asthma and COPD by cross-sectoral and multi-disciplinary collaboration in respiratory research, drug discovery and development.
The success of this approach depends on respiratory scientists with the competence to combine expertise across disciplines, and the skills to collaborate with experts from industry, healthcare and academia. Therefore, the goal of RESPIRE-EXCEL is to enable the transition to precision medicine for asthma and COPD by training the next generation of translational and physician scientists with the skills, cross-sectoral competences and multidisciplinary knowledge to identify the molecular mechanisms of asthma and COPD, develop improved prognostic and diagnostic biomarkers to detect their activity in individual patients, and support the development of novel treatments that target individual disease mechanisms, aiming to achieve stable remission of disease in asthma and COPD through precision medicine.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Academisch Ziekenhuis Groningen | Groningen | Netherlands | Coordinator |
| University of Technology Sydney | Sydney | Australia | Associatedpartner |
| Lungs Europe | Bruxelles / Brussel | Belgium | Associatedpartner |
| European Respiratory Society | Lausanne | Switzerland | Associatedpartner |
| Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt GmbH | Neuherberg | Germany | Participant |
| Ludwig-Maximilians-Universitaet Muenchen | Planegg | Germany | Associatedpartner |
| Universitaet Zu Luebeck | Lubeck | Germany | Associatedpartner |
| Universitatsklinikum Schleswig-Holstein | Lübeck | Germany | Participant |
| Kobenhavns Universitet | Kobenhavn | Denmark | Associatedpartner |
| Region Hovedstaden | Hillerod | Denmark | Participant |
| Consorcio Para La Explotacion Del Centro Nacional De Analisis Genomico | Barcelona | Spain | Associatedpartner |
| Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I Sunyer | Barcelona | Spain | Participant |
| Omniscope Espana SL | Barcelona | Spain | Participant |
| Universitat De Barcelona | Barcelona | Spain | Associatedpartner |
| Centre National De La Recherche Scientifique CNRS | Paris | France | Participant |
| Universite Cote D'azur | Nice | France | Associatedpartner |
| Rijksuniversiteit Groningen | Groningen | Netherlands | Associatedpartner |
| Umcg Research BV | Groningen | Netherlands | Associatedpartner |
| Karolinska Institutet | Stockholm | Sweden | Participant |
| Lunds Universitet | Lund | Sweden | Associatedpartner |
| Stockholms Universitet | Stockholm | Sweden | Participant |
| Astrazeneca UK Limited | Cambridge | United Kingdom | Associatedpartner |
| European Lung Foundation | Sheffield | United Kingdom | Associatedpartner |
| Imperial College of Science Technology and Medicine | London | United Kingdom | Associatedpartner |
| The Chancellor Masters and Scholars of the University of Cambridge | Cambridge | United Kingdom | Associatedpartner |
| University of Leicester | Leicester | United Kingdom | Associatedpartner |
| Cellarity, Inc | Somerville | United States | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI